Aker BioMarine posts strong earnings, but investments push down profits for 2018

The biotech innovator poured investments into research and developing technologies.

Matts Johansen, CEO Aker BioMarine
Matts Johansen, CEO Aker BioMarinePhoto: Aker
Published 19 July 2019, 08:12Updated 19 July 2019, 08:12